Spyre Therapeutics Inc (SYRE) Price Prediction & ForecastSYRESpyre Therapeutics Inc

Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $79.96 (+0.07%). The 1-week path is $78.60 (-1.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Spyre Therapeutics Inc is currently a hold. The stock is priced at $85.69, with a recent RSI of 49.58 indicating a neutral momentum. Although the stock has shown a remarkable year-to-date increase of 180.22% and a one-year increase of 353.03%, it has recently faced a 5-day decline of 8.05%. The forward P/E ratio is currently at 0, suggesting uncertainty in future earnings, while the analyst price targets range from $110 to $135, indicating potential upside. However, the significant insider selling, which increased by 796.31% over the last month, raises concerns about insider sentiment. Therefore, while there is potential for growth, the current risks and recent performance suggest a cautious approach is warranted.

Spyre Therapeutics Inc (SYRE) last closed at $79.9, losing -0.25%. These facts feed the 1-day and 1-week SYRE price prediction above.